A composition for improving skin condition and its application
By constructing nanocapsules encapsulating collagen peptides and total asiaticosides using a complex polysaccharide carrier, and combining a pH-responsive release mechanism with multiple skin-care ingredients, the problems of easy degradation of collagen peptides and poor water solubility of total asiaticosides are solved, achieving highly effective skin care results and stability, making it suitable for large-scale production.
Patent Information
- Application Number
- CN202511986181.4
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2025-12-26
- Publication Date
- 2026-11-10
- Estimated Expiration
- 2045-12-26
AI Technical Summary
In existing technologies, collagen peptides are easily hydrolyzed by gastric acid and have poor bioavailability, while total glycosides of Centella asiatica have poor water solubility and low intestinal absorption efficiency. Single carriers or ordinary processes cannot simultaneously solve the stability and absorption problems of both, and lack the synergistic effect to achieve multiple skin care benefits, resulting in limited effectiveness of related products.
Nanocapsules were constructed using a complex polysaccharide carrier to encapsulate collagen peptides and total glycosides from Centella asiatica. A stable carrier network was formed by the synergistic effect of konjac glucomannan, glucan, and xylooligosaccharides. Combined with a pH-responsive release mechanism, collagen-Centella asiatica nanocapsules were prepared and combined with ingredients such as sodium hyaluronate, compound berry juice powder, and niacinamide to form a multi-faceted skincare formula.
It achieves efficient encapsulation and stable release of collagen peptides and total glycosides of Centella asiatica, improves bioavailability, and synergistically achieves moisturizing and water-locking, improves skin elasticity and firmness, promotes collagen production and dermal density. The product has good storage stability and is suitable for large-scale production.
Smart Images

Figure SMS_1 
Figure SMS_2 
Figure SMS_3
Abstract
Description
Technical Field
[0001] This invention relates to the field of food technology, and more particularly to a composition for improving skin condition and its application. Background Technology
[0002] As people's demand for skin care increases, the application of oral functional skin care ingredients is becoming more and more widespread. However, the inherent defects of these ingredients limit their efficacy. Collagen peptides, as natural active peptides, have physiological functions such as promoting tissue repair and anti-oxidation, and have significant potential in improving skin elasticity and repair. However, after oral administration, they are easily hydrolyzed by gastric acid and degraded by gastrointestinal enzymes, resulting in a large loss of active ingredients and poor bioavailability. Centella asiatica total glycosides have anti-inflammatory and wound-healing activities and can help activate fibroblasts to promote collagen production in the skin. However, they have problems with poor water solubility and low intestinal absorption efficiency. The individual application or simple combination of these two ingredients cannot overcome their respective limitations and cannot fully realize their synergistic skin care value.
[0003] In existing technologies, single carriers or ordinary preparation processes cannot simultaneously solve the problems of gastrointestinal stability and absorption of these two active ingredients. Furthermore, there is a lack of formulation designs that can synergistically achieve multiple effects such as moisturizing and water-locking, anti-wrinkle, and improving skin elasticity and dermal density. As a result, the actual effects of related oral skin care products are limited and cannot meet consumers' demand for high-efficiency skin care.
[0004] Polysaccharide-based nanocarriers, with their advantages of good biocompatibility, biodegradability, and easy surface modification, can reduce the contact between active ingredients and the adverse gastrointestinal environment through spatial barrier, and at the same time, they can accurately release ingredients in suitable locations in the intestine by means of pH-responsive release mechanism, effectively improving the stability and absorption efficiency of active ingredients, and providing key technical support for the development of functional oral skin care products.
[0005] Based on this, the present invention proposes a composition for improving skin condition and its application, aiming to fully leverage the synergistic effect of each component through scientific formulation and advanced carrier technology, thereby overcoming the efficacy limitations of existing products. Summary of the Invention
[0006] The purpose of this invention is to address the shortcomings of existing oral functional skincare ingredients, such as the easy degradation and poor bioavailability of collagen peptides, the poor water solubility and low intestinal absorption efficiency of total asiaticoside, the inability of a single carrier or ordinary process to simultaneously solve the stability and absorption problems of both, and the lack of a formula that can synergistically achieve multiple skincare effects, resulting in limited effects of related products. Therefore, this invention proposes a composition for improving skin condition and its application.
[0007] To achieve the above objectives, the present invention adopts the following technical solution:
[0008] A composition for improving skin condition comprises the following components in parts by weight: 30-45 parts collagen-centella asiatica nanocapsules, 15-25 parts niacinamide, 20-30 parts compound berry juice powder, 3-8 parts sodium hyaluronate, 0.2-0.8 parts mogroside, and 0.1-0.3 parts compound fragrance.
[0009] Niacinamide is a B vitamin that can supplement vitamins, relieve fatigue, regulate skin function, and provide nutritional support for the skin. Compound berry juice powder is a blend of various berries containing vitamin C, anthocyanins, and other antioxidants, which can fight free radicals, delay aging, reduce wrinkles, promote gut health, and enhance immunity. Sodium hyaluronate is a high-molecular-weight mucopolysaccharide with strong moisturizing capabilities, locking in moisture, deeply hydrating, promoting skin cell regeneration and barrier repair, increasing skin elasticity, and brightening the complexion. Monk fruit glycosides can clear heat and moisten the lungs, soothe the throat, and relieve constipation. As a natural sweetener, it avoids the adverse effects of sugar on the skin and can maintain the stability of the body's internal environment, indirectly improving skin condition.
[0010] Preferably, the preparation method of the collagen-Centella asiatica nanocapsules includes the following steps:
[0011] (1) Dissolve konjac glucomannan in ultrapure water at 75-85℃ and stir for 25-35 minutes until completely dissolved to prepare a konjac glucomannan solution with a concentration of 1.2-1.8 mg / mL. Cool to room temperature and set aside.
[0012] (2) Add glucan and xylooligosaccharide to the konjac glucomannan solution, stir magnetically at 350-450 rpm for 15-25 min, and then adjust the pH to 5.2-6.2 to obtain the composite polysaccharide carrier solution;
[0013] (3) Add collagen peptides and total glycosides of Centella asiatica to the reaction vessel, then add ultrapure water to prepare a mixed solution with a total concentration of 2.5-3.5 mg / mL, then add vitamin C, then stir in a water bath at 45-55℃ for 20-30 min, set the power to 200-300W, and ultrasonically disperse for 8-12 min to obtain the composite core material;
[0014] (4) Add the composite core material to the composite polysaccharide carrier solution and stir magnetically at 300-400 rpm for 25-35 min. Then add calcium chloride solution with a mass fraction of 1.5-2.5% and stir at 28-32℃ for 25-35 min to obtain a nanocomposite suspension.
[0015] (5) Centrifuge the nanocomposite suspension at 10000-13000 rpm for 8-12 min to remove the precipitate, take the supernatant, add 4-6% of the supernatant mass of maltodextrin, stir evenly, then set the inlet air temperature to 125-135℃, the outlet air temperature to 55-65℃, the feed rate to 6-8 mL / min, and the atomization pressure to 0.35-0.45 MPa, collect the dried microcapsule powder, and finally pass it through a 100-120 mesh sieve to obtain collagen-Centella asiatica nanocapsules.
[0016] Preferably, in step (2), the mass ratio of konjac glucomannan, glucan, and xylooligosaccharide is 1:(0.4-0.6):(0.24-0.26). This mass ratio allows the three polysaccharides to work synergistically. Konjac glucomannan provides a strong gelling agent to construct the carrier framework, glucan enhances the hydrophilicity of the carrier, and xylooligosaccharide optimizes the structural support of the carrier. The appropriate ratio of the three can form a dense and stable composite polysaccharide carrier network, effectively improving the encapsulation effect on the composite core material and avoiding the problems of loose structure and low encapsulation rate that exist with single polysaccharide carriers.
[0017] Preferably, in step (3), the molecular weight of the collagen peptide is 500-1000 Da; the purity of the total asiaticoside is 80-85%; the mass ratio of the collagen peptide to the total asiaticoside is 1:(0.3-0.5); and the mass of the vitamin C is 0.04-0.06% of the mass of the mixed solution. This mass ratio of collagen peptide and total asiaticoside can synergistically promote collagen production and repair the skin. Adding vitamin C in this ratio can effectively protect the core material from oxidation and enhance the synergistic skincare effects of both.
[0018] Preferably, in step (4), the mass ratio of the composite core material to the composite polysaccharide carrier solution is 1:(5.5-6.5); the volume ratio of the composite polysaccharide carrier solution to the calcium chloride solution is 1:(3.8-4.2). This mass ratio of collagen peptides and total asiaticoside can synergistically promote collagen production and repair the skin; the appropriate amount of the cross-linking agent calcium chloride solution ensures sufficient cross-linking of the composite polysaccharide carrier, forming a dense, low-porosity capsule wall, thus enhancing the protective effect and stability of the microcapsules on the core material.
[0019] Using the above technical solution, konjac glucomannan is dissolved in ultrapure water and stirred until completely dissolved, laying the foundation for subsequent carrier construction. Based on this, dextran and xylooligosaccharides are added to the solution. Relying on the synergistic effect of the three, a stable composite polysaccharide carrier network is formed: konjac glucomannan builds the gel framework, dextran enhances the hydrophilicity of the carrier and fills pores, and xylooligosaccharides further optimize the density and overall stability of the carrier structure. Next, the composite core material is prepared simultaneously: collagen peptides and total asiaticoside are mixed, adjusted with ultrapure water, and then vitamin C is introduced. The antioxidant protection of vitamin C prevents the core material from oxidizing and becoming inactive, ultimately obtaining a stable composite core material. After the composite core material is prepared, it is thoroughly mixed with the composite polysaccharide carrier solution, and then calcium chloride is added. Utilizing the cross-linking effect of calcium chloride, the carrier shrinks, forming a dense capsule wall to firmly lock the core material, resulting in a nanocomposite suspension. To improve the purity of the system, impurities in the suspension are removed by centrifugation, and the supernatant is collected. Maltodextrin was subsequently added to the supernatant. Maltodextrin forms a protective film on the surface of the microcapsules, which improves the heat resistance of the microcapsules, reduces particle aggregation, and ensures water solubility in subsequent use. After the above treatment, the system was spray-dried, and the dried microcapsule powder was collected and sieved to finally obtain collagen-centella asiatica nanocapsules that can stably exert multiple effects.
[0020] Preferably, the compound berry juice powder is a mixture of red raspberry powder, blueberry powder, cranberry powder, and black chokeberry powder in a mass ratio of 1:(0.8-1.2):(0.8-1.2):(0.8-1.2).
[0021] Preferably, the method for preparing the composition includes the following steps:
[0022] Step 1: Weigh out the above components according to their respective weight proportions and set aside;
[0023] Step 2: Add collagen-centella asiatica nanocapsules, nicotinamide, compound berry juice powder, sodium hyaluronate and mogroside to a three-dimensional mixer and stir at 15-25 rpm for 20-30 minutes to obtain a mixed powder.
[0024] Step 3: Add the compound fragrance to the mixed powder and continue stirring at 15-25 rpm for 5-10 minutes to obtain the mixture;
[0025] Step 4: Pass the mixture through an 80-100 mesh sieve to remove agglomerated particles, thus obtaining the composition.
[0026] Through the above technical solution, the efficacy of the composition mainly lies in the synergistic effect of collagen-centella asiatica nanocapsules, sodium hyaluronate, compound berry juice powder, and niacinamide. In terms of moisturizing and water-locking, the composite polysaccharide carrier of the nanocapsules works in conjunction with sodium hyaluronate to construct a surface-level water-locking and deep-layer hydration network. Sodium hyaluronate moisturizes and penetrates to replenish moisture on the surface, while the microcapsule carrier adsorbs water and slowly releases active ingredients, achieving long-lasting moisturizing. Regarding promoting collagen production and increasing dermal density, the collagen-centella asiatica nanocapsules encapsulate collagen peptides that provide raw materials for collagen synthesis. Centella asiatica total glycosides activate fibroblast activity and related enzyme expression, promoting collagen production. The microcapsule's stable structure protects the active ingredients, while the antioxidant components of the compound berry juice powder reduce free radical damage. In addition, niacinamide optimizes the physiological environment and jointly enhances dermal density. To improve skin elasticity and firmness, nanocapsules promote collagen fiber production and stabilize the skin's supporting structure. Sodium hyaluronate hydrates and keeps collagen fibers moist and elastic. Microcapsule carriers and other components help repair the skin barrier and reduce the impact of external damage. In improving wrinkles around the eyes, nanocapsules act specifically on the eye area, releasing collagen peptides and total glycosides from Centella asiatica to fill collagen gaps. Sodium hyaluronate hydrates and fades wrinkles, while compound berry juice powder contains antioxidants to prevent collagen loss. Niacinamide regulates metabolism, working together to fade and prevent wrinkles around the eyes.
[0027] Compared with the prior art, the beneficial effects of the present invention are:
[0028] 1. Collagen-Centella Asiatica Nanocapsules: This invention constructs stable nanocapsules using a complex polysaccharide carrier to encapsulate collagen peptides and total asiatica glycosides, addressing the problems of easy hydrolysis of collagen peptides by gastric acid, poor water solubility of total asiatica glycosides, and poor intestinal absorption in traditional oral skincare products. The polysaccharide complex carrier improves the microcapsule encapsulation effect, and by utilizing pH-responsive release characteristics, it reduces the premature degradation of active ingredients in the gastric environment. The release rate in the intestinal environment is matched with the absorption process, which helps to improve bioavailability and allow both to exert their effects of promoting collagen production and repairing the skin.
[0029] 2. This invention, through the controlled microcapsule preparation and composition mixing process, results in products with better storage stability. Under refrigeration and accelerated storage conditions, the active ingredients are well preserved, superior to products prepared using traditional processes. Furthermore, the process steps are simple and controllable, and the mixing and drying equipment used is mature industrial-grade equipment. After sieving, the product is free of agglomerated particles and has good flowability, allowing it to be directly formulated into oral dosage forms such as solid beverages. This is suitable for large-scale production and helps solve the problems of poor stability and complex production processes in existing oral skincare products.
[0030] 3. The formula of this invention synergistically achieves the effects of moisturizing and locking in moisture, improving skin elasticity and firmness, promoting collagen production and increasing dermal density, and improving wrinkles around the eyes; the overall effect will decrease if any key ingredient is missing. At the same time, the components used have good biocompatibility and safety, and no adverse reactions have been observed in human trials, making the product suitable for long-term use and providing consumers with a safe oral skincare option. Detailed Implementation
[0031] The technical solutions in the embodiments of the present invention will be clearly and completely described below in conjunction with existing known technologies. Obviously, the described embodiments are only some embodiments of the present invention, and not all embodiments.
[0032] Example 1: Preparation of collagen-Centella asiatica nanocapsules:
[0033] (1) Dissolve 6.40g of konjac glucomannan in 5.3L of 75℃ ultrapure water and stir for 25min until completely dissolved to prepare a konjac glucomannan solution with a concentration of 1.2mg / mL. Cool to room temperature and set aside.
[0034] (2) Add 2.56g of glucan and 1.54g of xylooligosaccharide to the konjac glucomannan solution, stir magnetically at 350rpm for 15min, and then adjust the pH to 5.2 to obtain the composite polysaccharide carrier solution;
[0035] (3) Add 4.9g of collagen peptide and 1.47g of total glycosides of Centella asiatica to the reaction vessel, then add 2.5L of ultrapure water to prepare a mixed solution with a total concentration of 2.5mg / mL, then add 0.003g of vitamin C, then stir in a water bath at 45℃ for 20min, set the power to 200W, and ultrasonically disperse for 8min to obtain the composite core material;
[0036] (4) Add 7.4g of composite core material to 40.7g of composite polysaccharide carrier solution, stir magnetically at 300rpm for 25min, then add 20.3L of calcium chloride solution with a mass fraction of 1.5%, stir at 28℃ for 25min to obtain nanocomposite suspension;
[0037] (5) Centrifuge the nanocomposite suspension at 10,000 rpm for 8 min to remove the precipitate, take the supernatant, add 4% of the supernatant mass of maltodextrin, stir evenly, then set the inlet air temperature to 125℃, the outlet air temperature to 55℃, the feed rate to 6 mL / min, and the atomization pressure to 0.35 MPa, collect the dried microcapsule powder, and finally pass it through a 100-mesh sieve to obtain collagen-Centella asiatica nanocapsules.
[0038] Example 2: Preparation of collagen-Centella asiatica nanocapsules:
[0039] (1) Dissolve 6.50g of konjac glucomannan in 4.3L of 80℃ ultrapure water and stir for 30min until completely dissolved to prepare a konjac glucomannan solution with a concentration of 1.5mg / mL. Cool to room temperature and set aside.
[0040] (2) Add 3.25g of glucan and 1.63g of xylooligosaccharide to the konjac glucomannan solution, stir magnetically at 400rpm for 20min, and then adjust the pH to 6.0 to obtain the composite polysaccharide carrier solution;
[0041] (3) Add 4.60g of collagen peptide and 1.84g of total asiaticoside to the reaction vessel, then add 2.3L of ultrapure water to prepare a mixed solution with a total concentration of 2.8mg / mL, then add 0.0012g of vitamin C, then stir in a water bath at 50℃ for 25min, set the power to 280W, and ultrasonically disperse for 10min to obtain the composite core material;
[0042] (4) Add 7.8g of composite core material to 46.8g of composite polysaccharide carrier solution, stir magnetically at 350rpm for 30min, then add 12.4L of calcium chloride solution with a mass fraction of 2.0%, stir at 30℃ for 30min to obtain nanocomposite suspension;
[0043] (5) The nanocomposite suspension was centrifuged at 12000 rpm for 10 min to remove the precipitate. The supernatant was taken and 5% of the supernatant mass of maltodextrin was added. The mixture was stirred evenly. Then the inlet air temperature was set to 128℃, the outlet air temperature to 60℃, the feed rate to 7 mL / min, and the atomization pressure to 0.40 MPa. The dried microcapsule powder was collected and finally passed through a 110-mesh sieve to obtain collagen-Centella asiatica nanocapsules.
[0044] Example 3: Preparation of collagen-Centella asiatica nanocapsules:
[0045] (1) Dissolve 6.20g of konjac glucomannan in 3.4L of 85℃ ultrapure water and stir for 35min until completely dissolved to prepare a konjac glucomannan solution with a concentration of 1.8mg / mL. Cool to room temperature and set aside.
[0046] (2) Add 3.72g of glucan and 1.61g of xylooligosaccharide to the konjac glucomannan solution, stir magnetically at 450rpm for 25min, and then adjust the pH to 6.2 to obtain the composite polysaccharide carrier solution;
[0047] (3) Add 4.9g of collagen peptide and 2.45g of total glycosides of Centella asiatica to the reaction vessel, then add 2.1L of ultrapure water to prepare a mixed solution with a total concentration of 3.5mg / mL, then add 0.005g of vitamin C, then stir in a water bath at 55℃ for 30min, set the power to 300W, and ultrasonically disperse for 12min to obtain the composite core material;
[0048] (4) Add 7.4g of composite core material to 48.1g of composite polysaccharide carrier solution, stir magnetically at 400rpm for 35min, then add 14.5L of calcium chloride solution with a mass fraction of 2.5%, stir at 32℃ for 35min to obtain nanocomposite suspension;
[0049] (5) Centrifuge the nanocomposite suspension at 13000 rpm for 12 min to remove the precipitate, take the supernatant, add 6% of the supernatant mass of maltodextrin, stir evenly, then set the inlet air temperature to 135℃, the outlet air temperature to 65℃, the feed rate to 8 mL / min, and the atomization pressure to 0.45 MPa, collect the dried microcapsule powder, and finally pass it through a 120-mesh sieve to obtain collagen-Centella asiatica nanocapsules.
[0050] Comparative Example 1: Based on Example 2, the difference is that a single konjac glucomannan is used as the carrier, and glucomannan and xylooligosaccharides are removed, while the rest is the same as in Example 2.
[0051] Comparative Example 2: Based on Example 2, the difference is that a single dextran is used as the carrier, and konjac glucomannan and xylooligosaccharides are removed, while the rest is the same as in Example 2.
[0052] Comparative Example 3: Based on Example 2, the difference is that a single xylooligosaccharide is used as the carrier, and konjac glucomannan and glucan are removed, while the rest is the same as in Example 2.
[0053] Comparative Example 4: Based on Example 2, the difference is that the mass ratio of the composite core material to the composite polysaccharide carrier solution is 1:4, and the rest is the same as Example 2.
[0054] Comparative Example 5: Based on Example 2, the difference is that the volume ratio of the composite polysaccharide carrier solution to the calcium chloride solution is 1:3, and the rest is the same as in Example 2.
[0055] Comparative Example 6: Based on Example 2, the difference is that the original process is replaced by the "emulsification-curing method" commonly used in the prior art. Steps (4) and (5) are replaced by: mixing the composite core material with the composite polysaccharide carrier solution, emulsifying it for 5 minutes at 10,000 rpm using a high-speed homogenizer, directly dripping it into the calcium chloride solution for curing, filtering and drying it, and then sieving it. It does not undergo ultrasonic dispersion and spray drying. The rest is the same as in Example 2.
[0056] Collagen-Centella Asiatica Nanocapsule Performance Testing:
[0057] 1. Determination of encapsulation efficiency: During the preparation of nanocapsules, the remaining reaction solution was poured into a graduated cylinder and the volume V was measured. The concentration of collagen peptides was then determined by the biuret method or the concentration of total asiaticoside C was determined by HPLC. CV represents the amount of collagen peptides or total asiaticoside that were not encapsulated during the preparation of microcapsules. The encapsulation efficiency E was calculated according to the formula E=(G-CV) / G×100%, where G represents the total amount of collagen peptides or total asiaticoside added.
[0058] 2. Storage stability analysis: Collagen-Centella asiatica nanocapsules were placed in a refrigerator at 5°C and an incubator at 37°C. Samples were taken every 2 weeks for a total of 4 tests to determine the content of collagen peptides or total Centella asiatica glycosides.
[0059] 3. In vitro simulated digestion experiment:
[0060] 5.0 g of collagen-Centella asiatica nanocapsules were weighed and placed in two dissolution vessels. One dissolution vessel used 500 mL of artificial gastric fluid (prepared according to the method in the Chinese Pharmacopoeia: take 16.4 mL of dilute hydrochloric acid, add about 800 mL of water, add 10 g of pepsin, shake well, and then dilute with water to 1000 mL) as the medium; the other dissolution vessel used 500 mL of artificial intestinal fluid, i.e., phosphate buffer containing pancreatic enzymes, pH 6.8, as the medium. The experimental temperature was controlled at 37℃ and the rotation speed was 100 r / min. 5 mL samples were taken at 0.5, 1, 1.5, 2, 2.5, 3, 3.5, and 4 hours, respectively. After each sampling, 5 mL of fresh corresponding medium at the same temperature and volume was immediately added. The sample was immediately filtered through a 0.22μm microporous membrane, and the content of collagen peptides or total asiaticosides in the filtrate was determined to calculate the cumulative drug release percentage; thus, the release of collagen-asiaticoside nanocapsules in simulated gastric and intestinal fluid environments was determined.
[0061] The test results are as follows:
[0062] Table 1. Encapsulation efficiency test results of collagen peptides and total asiaticosides.
[0063]
[0064] Analysis of the data in Table 1 shows that the encapsulation efficiency of collagen peptides and total asiaticoside in the collagen-centella asiatica nanocapsules prepared in Examples 1-3 remained stable at 94.5%-95.8%. This indicates that the synergistic effect of the konjac glucomannan, glucan, and xylooligosaccharide polysaccharide composite carrier and the precise process parameters in the original process can form a dense and suitable capsule wall structure, achieving efficient encapsulation of the two active ingredients.
[0065] In contrast, the encapsulation efficiency of Comparative Examples 1-3 decreased significantly. This is because the single polysaccharide lacks the synergistic gel network of the polysaccharide composite carrier. The strong gelling properties of konjac glucomannan, the hydrophilicity of glucomannan, and the structural support of xylooligosaccharides cannot complement each other, resulting in a loose capsule wall structure and easy leakage of active ingredients. The decreased encapsulation efficiency of Comparative Example 4 was due to insufficient carrier dosage, which failed to completely encapsulate the composite core material, exposing some active ingredients to the outside of the carrier and leading to inadequate encapsulation. The decreased encapsulation efficiency of Comparative Example 5 was due to insufficient dosage of the cross-linking agent calcium chloride solution, resulting in insufficient cross-linking of the composite polysaccharide carrier, increased capsule wall porosity, and easy permeation and loss of active ingredients. Comparative Example 6 had the lowest encapsulation efficiency because the traditional process lacked the nanoscale homogenization treatment of ultrasonic dispersion and the precise molding of spray drying, leading to easy agglomeration of the core material and irregular capsule wall formation, making efficient encapsulation impossible.
[0066] Table 2. Storage stability test of collagen-centella asiatica nanocapsules at 5℃
[0067]
[0068] Table 3. Storage stability test of collagen-centella asiatica nanocapsules at 37℃
[0069]
[0070] Analysis of the data in Tables 2 and 3 shows that, under refrigeration at 5°C and accelerated storage at 37°C, the retention rates of collagen peptides and total asiaticoside in the nanocapsules of Examples 1-3 remained above 87% after 8 weeks. This indicates that the polysaccharide complex capsule wall effectively isolates external interferences such as oxygen and moisture. The protective effect of maltodextrin and the dense structure of spray drying together enhance the storage stability of the active ingredients, meeting the needs of industrial production and long-term storage.
[0071] The stability of Comparative Examples 1-3 was reduced. This is because the capsule wall structure of the single carrier lacks synergistic protection. For example, the gel strength of the xylooligosaccharide carrier is insufficient, and it cannot effectively prevent the external environment from eroding the core material; the dextran carrier is too hydrophilic and easily absorbs moisture, leading to oxidation of the core material; although the single konjac glucomannan carrier has a gel skeleton, it lacks the pore-filling and moisture-regulating effects of dextran and the structural reinforcement and antioxidant assistance of xylooligosaccharide, and therefore cannot form a synergistic protective effect of the polysaccharide complex carrier. Comparative Example 4 was stable. The reduced stability was due to insufficient complex polysaccharide carrier, resulting in insufficient capsule wall thickness, weakened protective barrier function, and accelerated oxidation and hydrolysis rate of active ingredients. The reduced stability in Comparative Example 5 was due to insufficient calcium chloride solution as a cross-linking agent, resulting in high capsule wall porosity, allowing oxygen and moisture to easily enter the capsule, accelerating the degradation of collagen peptides and oxidation of total asiaticoside. Comparative Example 6 had the worst stability because the traditional process resulted in irregular microcapsule morphology, loose capsule walls, and no maltodextrin protection, leaving the active ingredients directly exposed to the environment, significantly accelerating the degradation rate.
[0072] Table 4. Cumulative release rate of collagen peptides in simulated gastric and intestinal fluids.
[0073]
[0074] Table 5. Cumulative release rate of total asiaticosides in simulated gastric and intestinal fluids.
[0075]
[0076] Analysis of the data in Tables 4 and 5 shows that the cumulative release rate of the nanocapsules in Examples 1-3 in the simulated gastric environment was only 27.6%-30.3%, and the release rate was slow. This is because the dense capsule wall formed by the polysaccharide composite carrier is structurally stable under acidic conditions, effectively blocking gastric acid erosion and preventing premature release and degradation of the core material, thus achieving a protective function in the stomach. After entering the simulated intestinal environment, the release rate significantly increased, reaching a cumulative release rate of 69.8%-73.2% after 4 hours, and the release curve was smooth. This is because the neutral to slightly alkaline environment of the intestinal fluid triggers moderate swelling of the gel network of the polysaccharide composite carrier, slowly expanding the pores of the capsule wall, and gradually diffusing and releasing the core material, matching the absorption rate of intestinal epithelial cells and improving bioavailability.
[0077] Comparative Examples 1-3 showed release rates of 28.6%-36.4% in the gastric environment within 0.5 hours, and over 50% within 2 hours, exhibiting a "burst release" characteristic. This is because the single polysaccharide carrier cannot form a synergistic gel network, the capsule wall is prone to swelling and rupture under acidic conditions, and the core material leaks prematurely. Although the cumulative release rate in the intestinal environment after 4 hours was higher than in the examples, the release curve was steep. In Comparative Example 4, the mass ratio of the composite core material to the carrier was lower than the optimal range, resulting in insufficient capsule wall thickness and incomplete structure. The controlled release capability in the intestinal environment was significantly reduced, the active ingredient remained in the gastrointestinal tract for a short time, and the absorption efficiency was reduced. In Comparative Example 5, the volume ratio of the calcium chloride solution was lower than the optimal range, the degree of cross-linking of the composite polysaccharide carrier was insufficient, the capsule wall porosity increased, the release curve in the intestinal environment fluctuated, and the release behavior was irregular, making it impossible to guarantee stable absorption of the active ingredient. The microcapsules prepared in Comparative Example 6 had irregular morphology, loose capsule walls, and no maltodextrin protection. The release rates in both the gastric and intestinal environments exhibited a "burst release" characteristic throughout the entire process. The core material degrades significantly in the stomach. Although it is fully released in the intestines, the effective ingredients are severely lost, and the aggregation of the core material leads to uneven release.
[0078] In summary, Examples 1-3 achieved efficient encapsulation, stable storage, and ideal controlled release of the two active ingredients by optimizing the structure and process parameters of the composite polysaccharide carrier. Comparative Examples 1-6, due to the lack of polysaccharide synergy, insufficient carrier, insufficient cross-linking agent, or the use of traditional processes, had reduced encapsulation efficiency and stability, abnormal release, and their overall performance was far inferior to that of the Examples.
[0079] Example 4: A method for preparing a composition for improving skin condition, comprising the following steps:
[0080] Step 1: Weigh out 30g of collagen-centella asiatica nanocapsules, 15g of niacinamide, 20g of compound berry juice powder, 3g of sodium hyaluronate, 0.2g of monk fruit glycosides, and 0.1g of compound flavoring, and set aside.
[0081] Step 2: Add collagen-centella asiatica nanocapsules, nicotinamide, compound berry juice powder, sodium hyaluronate and mogroside to a three-dimensional mixer and stir at 15 rpm for 20 minutes to obtain a mixed powder.
[0082] Step 3: Then add the compound fragrance to the mixed powder and continue stirring at 15 rpm for 5 minutes to obtain the mixture;
[0083] Step 4: Pass the mixture through an 80-mesh sieve to remove agglomerated particles, thus obtaining the composition.
[0084] The compound berry juice powder is prepared by weighing red raspberry powder, blueberry powder, cranberry powder and black chokeberry powder in a mass ratio of 1:0.8:0.8:0.8 and then mixing them. The preparation method of the collagen-centella asiatica nanocapsules is the same as in Example 2.
[0085] Example 5: A method for preparing a composition for improving skin condition, comprising the following steps:
[0086] Step 1: Weigh out 40g of collagen-centella asiatica nanocapsules, 20g of niacinamide, 24g of compound berry juice powder, 5g of sodium hyaluronate, 0.4g of monk fruit glycosides, and 0.2g of compound flavoring, and set aside.
[0087] Step 2: Add collagen-centella asiatica nanocapsules, nicotinamide, compound berry juice powder, sodium hyaluronate and mogroside to a three-dimensional mixer and stir at 20 rpm for 25 minutes to obtain a mixed powder.
[0088] Step 3: Then add the compound fragrance to the mixed powder and continue stirring at 20 rpm for 8 minutes to obtain the mixture;
[0089] Step 4: Pass the mixture through a 90-mesh sieve to remove agglomerated particles, thus obtaining the composition.
[0090] The compound berry juice powder is prepared by weighing red raspberry powder, blueberry powder, cranberry powder and black chokeberry powder in a mass ratio of 1:1:1:1 and then mixing them; the preparation method of the collagen-centella asiatica nanocapsules is the same as in Example 2.
[0091] Example 6: A method for preparing a composition for improving skin condition, comprising the following steps:
[0092] Step 1: Weigh out 45g of collagen-centella asiatica nanocapsules, 25g of niacinamide, 30g of compound berry juice powder, 8g of sodium hyaluronate, 0.8g of monk fruit glycosides, and 0.3g of compound flavoring, and set aside.
[0093] Step 2: Add collagen-centella asiatica nanocapsules, nicotinamide, compound berry juice powder, sodium hyaluronate and mogroside to a three-dimensional mixer and stir at 25 rpm for 30 minutes to obtain a mixed powder.
[0094] Step 3: Then add the compound fragrance to the mixed powder and continue to stir at 25 rpm for 10 minutes to obtain the mixture;
[0095] Step 4: Pass the mixture through a 100-mesh sieve to remove agglomerated particles, thus obtaining the composition.
[0096] The compound berry juice powder is prepared by weighing red raspberry powder, blueberry powder, cranberry powder and black chokeberry powder in a mass ratio of 1:1.2:1.2:1.2 and then mixing them. The preparation method of the collagen-centella asiatica nanocapsules is the same as in Example 2.
[0097] Comparative Example 7: Based on Example 5, the difference is that in the first and second steps, collagen-Centella asiatica nanocapsules were replaced with 28.6g of collagen peptides and 11.4g of total Centella asiatica glycosides, and the rest were the same as in Example 5.
[0098] Comparative Example 8: Based on Example 5, the difference is that collagen-Centella asiatica nanocapsules are replaced with collagen peptide nanocapsules in the first and second steps; the preparation method of collagen peptide nanocapsules is the same as that of collagen-Centella asiatica nanocapsules, except that the total glycosides of Centella asiatica are removed in step (3) to prepare them, and the rest is the same as in Example 5.
[0099] Comparative Example 9: Based on Example 5, the difference is that in the first and second steps, collagen-Centella asiatica nanocapsules are replaced with Centella asiatica total glycoside nanocapsules; the preparation method of Centella asiatica total glycoside nanocapsules is the same as that of collagen-Centella asiatica nanocapsules, except that collagen peptides are removed in step (3) to prepare them, and the rest is the same as in Example 5.
[0100] Comparative Example 10: Based on Example 5, the difference is that collagen-Centella asiatica nanocapsules were replaced with collagen peptides in the first and second steps, and the rest was the same as in Example 5.
[0101] Comparative Example 11: Based on Example 5, the difference is that in the first and second steps, collagen-Centella asiatica nanocapsules were replaced with total Centella asiatica glycosides, and the rest was the same as in Example 5.
[0102] Comparative Example 12: Based on Example 5, the difference is that the compound berry juice powder is removed in the first and second steps, and the rest is the same as Example 5.
[0103] Comparative Example 13: Based on Example 5, the difference is that sodium hyaluronate is removed in the first and second steps, and the rest is the same as in Example 5.
[0104] Comparative Example 14: Based on Example 5, the difference is that collagen-Centella asiatica nanocapsules were removed in the first and second steps, otherwise it was the same as Example 5.
[0105] Composition efficacy testing:
[0106] The compositions prepared in Examples 4-6 and Comparative Examples 7-14 were packaged into 4000 solid beverage packets with a specification of 6.8g / packet, and efficacy tests were conducted.
[0107] Thirty-three eligible participants were selected for testing. Participants applied the test product in the designated testing area according to the experimental protocol. Participants ingested two sachets daily for four weeks. The method of consumption was to add the product to 150-200mL of warm water (not exceeding 55℃), stir well, and drink. Throughout the testing period, participants avoided prolonged sun exposure, outdoor exercise, travel, and the use of cosmetics or medications with similar effects to the product. Participants also maintained their daily skincare routines. The testing environment was maintained at a temperature of 20-22℃ and a humidity of 40-60%RH.
[0108] Evaluation indicators:
[0109] (1) Stratum corneum moisture content: The stratum corneum moisture content tester Cormeometer CM825 (Courage & Khazaka, Germany) was used for testing. The average value was taken after 6 tests. The higher the value, the higher the stratum corneum moisture content. The unit is Cormeometer Unit, abbreviated as CU.
[0110] (2) Transdermal water loss: The Tewameter™ 300 (Courage & Khazaka, Germany) skin surface water loss tester was used for testing. The average value was taken after 3 tests. The lower the value, the less transdermal water loss. The unit is g / (h·m²).
[0111] (3) Skin elasticity and firmness: The skin elasticity tester Cutometer MPA580 (Courage & Khazaka, Germany) was used for testing. Each index was tested 3 times and the average value was taken. The higher the skin elasticity R2 and R5 values, the better the skin elasticity. The lower the skin firmness F4 value, the better the skin firmness. All of these are dimensionless indicators.
[0112] (4) Wrinkle-related indicators: The DermaTOP-V3 (EO-TECH, France) skin rapid optical imaging system was used for testing. The frontal image of the test area was acquired once and the image analysis was performed once. The lower the wrinkle area value, the smaller the wrinkle area in the test area (unit: mm²). The lower the wrinkle volume value, the shallower the wrinkle in the test area (unit: mm³). The wrinkle depth result is presented as a negative number and the higher the absolute value, the deeper the wrinkle in the test area (unit: mm).
[0113] (5) Dermal density: The skin ultrasound tester Ultrasound & DermaLab® Series SkinLab Combo (CORTEXTECHNOLOGY, Denmark) was used for testing. One image was acquired and one image analysis was performed. The higher the value, the higher the dermal density and the higher the collagen content. The unit is %.
[0114] (6) Collagen content at 2mm of skin: The intradermal spectrophotometer SIAMETRICSSIAscopeV (MedxHealthCorp, Canada) was used for testing. One image was acquired and one image analysis was performed. This value represents the relative concentration of collagen at 2mm of skin. The higher the value, the higher the collagen content. It is a dimensionless indicator.
[0115] The following data are all averages of all subjects' data: BL represents before the trial; W4 represents after 4 weeks of trial; rate of change (%) = [(W4-BL) / BL] × 100%; the test results are as follows:
[0116] Table 6. Test results of moisturizing-related indicators
[0117]
[0118] Analysis of the data in Table 6 shows that the stratum corneum moisture content enhancement rate and transepidermal water loss reduction rate of Examples 4-6 are significantly better than all comparative examples.
[0119] Comparative Examples 7-11 showed reduced moisturizing effects by replacing or separating the collagen-Centella asiatica nanocapsules. Comparative Examples 10 and 11, in particular, lacked the water-locking effect of the microcapsule wall polysaccharides, resulting in significantly lower stratum corneum and transepidermal water content compared to Examples 4-6. This highlights the dual moisturizing value of the nanocapsule carrier and core material. Comparative Example 12, by removing the compound berry juice powder, showed that the natural polysaccharides and antioxidants in the compound berries could help improve skin hydration, but its water content increase rate was lower than in the examples, verifying its auxiliary moisturizing effect. Comparative Example 13, lacking the core moisturizing component, showed a stratum corneum water content change rate of only 8.51% and a transepidermal water loss reduction rate of only 6.76%, verifying the core hydrating effect of sodium hyaluronate. Comparative Example 14, lacking the water-locking function of the microcapsule wall polysaccharides, had the worst moisturizing effect, with a water content increase rate of only 7.38%, further demonstrating the water-locking value of the compound polysaccharides.
[0120] Table 7 Results of Skin Elasticity Test
[0121]
[0122] Table 8 Results of the F4 Skin Firmness Test
[0123]
[0124] Analysis of the data in Tables 7 and 8 shows that the compositions prepared in Examples 4-6 showed the best performance in improving skin elasticity and firmness, which is mainly due to the synergistic effect of collagen-centella asiatica nanocapsules and other components.
[0125] Regarding skin elasticity and firmness, the comparative groups showed significantly lower results than the example groups due to impaired core components or formula integrity: For skin elasticity, comparative groups 7-9, due to the replacement or disassembly of collagen-centella asiatica nanocapsules, exhibited lower R2 and R5 change rates than the example groups; comparative groups 10-11, using a single active ingredient without microcapsule encapsulation, showed even smaller improvements in elasticity; comparative groups 12-13, lacking some formula components, also showed lower R2 and R5 change rates than the example groups; comparative group 14, having completely removed the core collagen-centella asiatica nanocapsules, showed the worst improvement in elasticity. Regarding skin firmness, comparative groups 7-9 showed an F4 value change rate of only -2.94% to -3.02%, comparative groups 10-11 showed even lower improvements in firmness, and comparative groups 12-13 also showed lower improvements than the example groups; comparative group 14, lacking the core microcapsules, showed the lowest improvement in firmness. These findings confirm the crucial role of the collagen-centella asiatica nanocapsules in structural protection, the synergistic effect of the composite core material, and the integrity of the formulation in improving skin elasticity and firmness.
[0126] Table 9. Test results of collagen and dermal density indices.
[0127]
[0128] Analysis of the data in Table 9 shows that the collagen content improvement rate and dermal density improvement rate of the groups of Examples 4-6 are the best, and the core is the synergistic effect of collagen-Centella asiatica nanocapsules.
[0129] In Comparative Example 7, the active ingredients collagen and total asiaticoside were not protected by microcapsules and were easily degraded by the gastrointestinal tract. The collagen content increase rate was 1.11%, and the dermal density increase rate was 6.50%, verifying the active protective value of microcapsules. Comparative Examples 8 and 9 lacked the synergistic effect of collagen peptides and total asiaticoside, and the collagen content and dermal density increase rates were significantly lower than in the example. Comparative Examples 10 and 11 had no microcapsule structure and were single active ingredients, resulting in low collagen content and dermal density increase rates. Comparative Example 12 did not contain compound berry juice powder. The anthocyanins in compound berries can reduce collagen oxidation and decomposition, so its dermal density increase rate was lower than in the example, verifying the auxiliary protective effect of compound berries. Comparative Example 13 did not contain sodium hyaluronate. Sodium hyaluronate can improve the moisture environment of the dermis and indirectly promote collagen production, so its collagen content and dermal density increase rate were lower than in the example. Comparative Example 14 had low collagen content and dermal density increase rates, highlighting the irreplaceable nature of the microcapsule composite core material.
[0130] Table 10 Results of Tests on Indicators Related to Crow's Feet Wrinkles
[0131]
[0132] Table 11 Results of Tests on Indicators Related to Fine Lines Under the Eyes
[0133]
[0134] Analysis of the data in Tables 10 and 11 shows that: Examples 4-6 showed the best improvement rates in the area, volume, and depth of wrinkles at the corners of the eyes and under the eyes; Comparative Example 7, lacking microcapsule structures, had low bioavailability of the active ingredients collagen peptides and total asiaticoside, resulting in a lower wrinkle improvement rate than the examples; Comparative Examples 8 and 9 lacked the synergistic effect of collagen peptides and total asiaticoside, leading to lower improvement rates than the examples; Comparative Examples 10 and 11, without microcapsules and containing only a single active ingredient, showed relatively low improvement rates; Comparative Example 12... The wrinkle improvement rate of the control group was significantly lower than that of the control group, verifying the antioxidant and anti-wrinkle effects of the compound berry. Its anthocyanins can scavenge free radicals, reduce collagen fiber breakage, and help to reduce wrinkles. The control group 13 did not contain sodium hyaluronate. Sodium hyaluronate can fill the gaps in the skin and indirectly reduce fine lines, so its wrinkle improvement rate was lower than that of the control group, verifying the auxiliary anti-wrinkle effect of sodium hyaluronate. The control group 14 did not contain collagen-centella asiatica nanocapsules, and the improvement effect of under-eye wrinkles and fine lines was poor, which highlights the core value of the microcapsule composite core material.
[0135] The above description is only a preferred embodiment of the present invention, but the scope of protection of the present invention is not limited thereto. Any equivalent substitutions or modifications made by those skilled in the art within the scope of the technology disclosed in the present invention, based on the technical solution and inventive concept of the present invention, should be covered within the scope of protection of the present invention.
Claims
1. A pharmaceutical composition for improving skin condition, characterized in that, It is composed of the following components in parts by weight: 30-45 parts collagen-centella asiatica nanocapsules, 15-25 parts niacinamide, 20-30 parts compound berry juice powder, 3-8 parts sodium hyaluronate, 0.2-0.8 parts mogroside, and 0.1-0.3 parts compound fragrance; The preparation method of the collagen-centella asiatica nanocapsules includes the following steps: (1) Dissolve konjac glucomannan in ultrapure water at 75-85℃ and stir for 25-35 minutes until completely dissolved to prepare a konjac glucomannan solution with a concentration of 1.2-1.8 mg / mL. Cool to room temperature and set aside. (2) Add glucan and xylooligosaccharide to the konjac glucomannan solution, stir magnetically at 350-450 rpm for 15-25 min, and then adjust the pH to 5.2-6.2 to obtain the composite polysaccharide carrier solution; (3) Add collagen peptides and total glycosides of Centella asiatica to the reaction vessel, then add ultrapure water to prepare a mixed solution with a total concentration of 2.5-3.5 mg / mL, then add vitamin C, then stir in a water bath at 45-55℃ for 20-30 min, set the power to 200-300W, and ultrasonically disperse for 8-12 min to obtain the composite core material; (4) Add the composite core material to the composite polysaccharide carrier solution and stir magnetically at 300-400 rpm for 25-35 min. Then add a calcium chloride solution with a mass fraction of 1.5-2.5% and stir at a constant temperature of 28-32℃ for 25-35 min to obtain a nanocomposite suspension. The mass ratio of the composite core material to the composite polysaccharide carrier solution is 1:(5.5-6.5); the volume ratio of the composite polysaccharide carrier solution to the calcium chloride solution is 1:(3.8-4.2). (5) Centrifuge the nanocomposite suspension at 10000-13000 rpm for 8-12 min to remove the precipitate, take the supernatant, add 4-6% of the supernatant mass of maltodextrin, stir evenly, then set the inlet air temperature to 125-135℃, the outlet air temperature to 55-65℃, the feed rate to 6-8 mL / min, and the atomization pressure to 0.35-0.45 MPa, collect the dried microcapsule powder, and finally pass it through a 100-120 mesh sieve to obtain collagen-Centella asiatica nanocapsules.
2. The pharmaceutical composition according to claim 1, characterized in that, In step (2), the mass ratio of konjac glucomannan, glucan and xylooligosaccharide is 1:(0.4-0.6):(0.24-0.26).
3. The pharmaceutical composition according to claim 1, characterized in that, In step (3), the molecular weight of the collagen peptide is 500-1000 Da; the purity of the total asiaticoside is 80-85%; the mass ratio of the collagen peptide to the total asiaticoside is 1:(0.3-0.5); and the mass of the vitamin C is 0.04-0.06% of the mass of the mixed solution.
4. The pharmaceutical composition according to claim 1, characterized in that, The compound berry juice powder is a mixture of red raspberry powder, blueberry powder, cranberry powder, and black chokeberry powder in a mass ratio of 1:(0.8-1.2):(0.8-1.2):(0.8-1.2).
5. A method for preparing a pharmaceutical composition according to any one of claims 1-4, characterized in that, Includes the following steps: Step 1: Weigh out the above components according to their respective weight proportions and set aside; Step 2: Add collagen-centella asiatica nanocapsules, nicotinamide, compound berry juice powder, sodium hyaluronate and mogroside to a three-dimensional mixer and stir at 15-25 rpm for 20-30 minutes to obtain a mixed powder. Step 3: Add the compound fragrance to the mixed powder and continue stirring at 15-25 rpm for 5-10 minutes to obtain the mixture; Step 4: Pass the mixture through an 80-100 mesh sieve to remove agglomerated particles, thus obtaining the composition.
Citation Information
Patent Citations
Skin care product for preventing and treating striae gravidarum and preparation method of skin care product
CN106913485A
Skin-care composition, preparation method therefor and use thereof
WO2024031762A1
